학술논문
Online haemodiafiltration: definition, dose quantification and safety revisited
Document Type
Academic Journal
Author
Tattersall, James E.; Ward, Richard A.; Canaud, Bernard; Blankestijn, Peter J.; Bots, Michiel; Covic, Adrian; Davenport, Andrew; Grooteman, Muriel; Gura, Victor; Hegbrant, Jörgen; Hoffmann, Joerg; Hothi, Daljit; Hutchison, Colin; Kircelli, Fatih; Krieter, Detlef; Kuhlmann, Martin; Ledebo, Ingrid; Locatelli, Francesco; Maduell, Francisco; Martin-Malo, Alejandro; Nicoud, Philippe; Nubé, Menso; Ok, Ercan; Pedrini, Luciano; Port, Friedrich; Ragon, Alain; Santoro, Antonio; Schindler, Ralf; Shroff, Rukshana; Tattersall, James; Vanholder, Raymond; Ward, Richard
Source
Nephrology Dialysis Transplantation. Mar 01, 2013 28(3):542-550
Subject
Language
English
ISSN
0931-0509
Abstract
The general objective assigned to the EUropean DIALlysis (EUDIAL) Working Group by the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) was to enhance the quality of dialysis therapies in Europe in the broadest possible sense. Given the increasing interest in convective therapies, the Working Group has started by focusing on haemodiafiltration (HDF) therapies. Several reports suggest that those therapies potentially improve the outcomes for end-stage renal disease patients. Europe is the leader in the field, having introduced the concept of ultra-purity for water and dialysis fluids and with notified bodies of the European Community having certified water treatment systems and online HDF machines. The prevalence of online HDF-treated patients is steadily increasing in Europe, averaging 15%. A EUDIAL consensus conference was held in Paris on 13 October 2011 to revisit terminology, safety and efficacy of online HDF. This is the first report of the expert group arising from that conference.